Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue

NORTH CHICAGO, Ill., June 26, 2019 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of June 24, 2019 its issued share capital, excluding treasury shares, is comprised of 1,478,365,231 shares of common stock with... Read more ››

By: PR Newswire Association LLC. - 26 Jun 2019
Related companies:  AbbVie Inc.

DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions

TEL AVIV, Israel and SAN FRANCISCO, June 26, 2019 /PRNewswire/ -- DayTwo, the microbiome human discovery platform that offers a glycemic... Read more ››

By: PR Newswire Association LLC. - 26 Jun 2019
Related companies:  DayTwo

West Health Policy Center Expands Team, Boosting Commitment To Lowering Healthcare And Prescription Drug Costs

WASHINGTON, June 26, 2019 /PRNewswire/ -- The West Health Policy Center has appointed Read more ››

By: PR Newswire Association LLC. - 26 Jun 2019

Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform

SOUTH SAN FRANCISCO, Calif., June 26, 2019 /PRNewswire/ -- Encoded Therapeutics, Inc. (Encoded), a precision gene therapy company,... Read more ››

By: PR Newswire Association LLC. - 26 Jun 2019

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

RIDGEFIELD, Conn. and INDIANAPOLIS, June 26, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to empagliflozin for the reduction of the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure,... Read more ››

By: PR Newswire Association LLC. - 26 Jun 2019
Related companies:  Eli Lilly and Company

Cambium Networks Corporation Announces Pricing of Initial Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019

Helsinn appoints Giorgio Calderari, Group General Manager and Chief Operating Officer, to the Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019

Innate Pharma announces publication of IPH4102 Phase I clinical trial results for CTCL in the Lancet Oncology

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Innate Pharma S.A.

The Laser Skin Center Medical Spa Receives "Top Medical Spa East" in the 2019 Aesthetic Everything® Aesthetic and Cosmetic Medicine Awards

BOSTON, June 25, 2019 /PRNewswire/ -- The Laser Skin Center Medical Spa Receives "Top Medical Spa East" in the 2019 Aesthetic Everything(®) Aesthetic and Cosmetic Medicine Awards. This year's 2019 Aesthetic Everything® Awards tapped winners from over 40,000 votes cast.

Read more ››
By: PR Newswire Association LLC. - 26 Jun 2019

ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders

HOUSTON, TX AND VANCOUVER, June 25, 2019 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce the results of the votes... Read more ››

By: PR Newswire Association LLC. - 26 Jun 2019
Related companies:  ESSA Pharma Inc.

Wildflower Announces Closing of Private Placement

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019

The global sinusitis drugs market size at a CAGR of over 6% during the forecast period

NEW YORK, June 25, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 26 Jun 2019

In the device type segment of the spinal surgery devices market, spinal fusion is believed to have the largest market size and is expected to witness a CAGR of 3.22%

NEW YORK, June 25, 2019 /PRNewswire/ --

Market Overview
The global spinal surgery devices market was valued at USD 8,339.81 million in 2018 and is estimated to be valued at USD 10,108.80 million in 2024, witnessing a CAGR of 3.15%. The key factors propelling the growth... Read more ››

By: PR Newswire Association LLC. - 26 Jun 2019

Paratek Pharmaceuticals Promotes Evan Loh, M.D. to Chief Executive Officer; Michael Bigham to Assume Role of Executive Chairman

Read more ››
By: Nasdaq / GlobenewsWire - 25 Jun 2019
Related companies:  Paratek Pharmaceuticals, Inc.

Assembly Biosciences Announces Participation in the Microbiome Movement Drug Development Summit

Read more ››
By: Nasdaq / GlobenewsWire - 25 Jun 2019
Related companies:  Assembly Biosciences, Inc.

Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: Nasdaq / GlobenewsWire - 25 Jun 2019
Related companies:  Atara Biotherapeutics, Inc.

Global Blood Therapeutics Announces Proposed Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 25 Jun 2019
Related companies:  Global Blood Therapeutics Inc.

Medtronic Announces Pricing of €5 Billion of Senior Notes

Read more ››
By: Nasdaq / GlobenewsWire - 25 Jun 2019
Related companies:  Medtronic Plc

Medtronic Announces the Upsizing of its Maximum Tender Offer to up to $4.35 billion for Certain Outstanding Debt Securities Issued by Medtronic, Inc., Medtronic Global Holdings S.C.A. and Covidien International Finance S.A.

Read more ››
By: Nasdaq / GlobenewsWire - 25 Jun 2019
Related companies:  Medtronic Plc

AIT Therapeutics Reports Financial Results for Fiscal Fourth Quarter and Year-End 2019 Results

Read more ››
By: Nasdaq / GlobenewsWire - 25 Jun 2019
Related companies:  AIT Therapeutics Inc.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑